Eric Nash, MD
Otolaryngology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Nash’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G70770 · Current
Licensed to practise in California · since 1991 · expires 2028-03-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$9,952
Medicare paid this office $9,952 for 112 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 29 | $1,788 | $62 |
| New patient visit (45+ min) | 12 | $1,205 | $100 |
| New patient visit (45+ min) | 12 | $1,191 | $99 |
| Short return visit (20+ min) | 17 | $953 | $50 |
| New patient visit (30+ min) | 16 | $949 | $59 |
See all 7 services
| New patient visit (30+ min) | 29 | $1,788 | $62 |
| New patient visit (45+ min) | 12 | $1,205 | $100 |
| New patient visit (45+ min) | 12 | $1,191 | $99 |
| Short return visit (20+ min) | 17 | $953 | $50 |
| New patient visit (30+ min) | 16 | $949 | $59 |
| Short return visit (20+ min) | 12 | $696 | $50 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 22 | $312 | $12 |
Who their Medicare patients are
112 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 14% · Women 55% · Also on Medicaid 22% · Health risk score 1.26. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 34% · COPD 28% · Chronic kidney disease 24% · Atrial fibrillation 23% · Depression 21% · Heart failure 17% · Cancer 14%.
The office billed $37,564, Medicare allowed $12,483 and paid $9,952; for 189 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 112 | 189 | 74 | 1.26 | $37,564 | $9,952 |
| 2023 | 182 | 267 | 74 | 1.24 | $90,766 | $20,427 |
| 2022 | 315 | 568 | 72 | 1.37 | $157,891 | $45,072 |
| 2021 | 253 | 492 | 70 | 1.20 | $140,996 | $45,083 |
| 2020 | 273 | 574 | 70 | 1.45 | $173,728 | $50,360 |
| 2019 | 231 | 444 | 71 | 1.35 | $114,428 | $33,875 |
| 2018 | 310 | 779 | 73 | 1.17 | $143,187 | $52,267 |
| 2017 | 378 | 808 | 74 | 1.16 | $113,126 | $54,660 |
| 2016 | 388 | 998 | 76 | 1.43 | $106,440 | $70,940 |
| 2015 | 334 | 807 | 75 | 1.15 | $92,938 | $60,453 |
| 2014 | 248 | 539 | 76 | 1.12 | $66,153 | $42,211 |
| 2013 | 293 | 734 | 75 | 1.03 | $91,410 | $59,158 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| New patient visit (45+ min) | 87 | $8,772 | $101 |
| New patient visit (30+ min) | 63 | $5,260 | $83 |
| Return visit (30+ min) | 22 | $1,846 | $80 |
| Short return visit (20+ min) | 35 | $1,733 | $48 |
| Removal of impacted ear wax | 34 | $952 | $26 |
2022: 8 services
| New patient visit (30+ min) | 148 | $11,265 | $76 |
| New patient visit (45+ min) | 84 | $9,996 | $119 |
| Return visit (30+ min) | 37 | $4,531 | $96 |
| Short return visit (20+ min) | 66 | $4,499 | $60 |
| Removal of impacted ear wax | 69 | $2,825 | $34 |
| Diagnostic exam of voice box using a flexible endoscope | 18 | $2,417 | $110 |
| Short return visit | 27 | $1,076 | $34 |
| New patient visit (15+ min) | 12 | $636 | $53 |
2021: 8 services
| New patient visit (45+ min) | 111 | $12,879 | $116 |
| Telephone medical discussion with physician, 21-30 minutes | 61 | $7,647 | $101 |
| Return visit (30+ min) | 48 | $5,483 | $95 |
| New patient visit (30+ min) | 49 | $4,093 | $84 |
| Short return visit (20+ min) | 38 | $3,534 | $71 |
| Removal of impacted ear wax | 46 | $2,250 | $37 |
| Diagnostic exam of voice box using a flexible endoscope | 19 | $2,187 | $104 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,378 | $77 |
2020: 9 services
| New patient visit (45+ min) | 152 | $17,105 | $113 |
| Return visit (30+ min) | 61 | $5,926 | $86 |
| Short return visit (20+ min) | 62 | $5,572 | $57 |
| New patient visit (30+ min) | 61 | $4,649 | $76 |
| Telephone medical discussion with physician, 21-30 minutes | 35 | $3,608 | $93 |
| Diagnostic exam of voice box using a flexible endoscope | 20 | $2,393 | $104 |
| Removal of impacted ear wax | 41 | $2,097 | $37 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,113 | $80 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,021 | $64 |
2019: 6 services
| New patient visit (45+ min) | 93 | $9,827 | $106 |
| New patient visit (30+ min) | 94 | $7,565 | $80 |
| Short return visit (20+ min) | 69 | $4,653 | $51 |
| Return visit (30+ min) | 42 | $3,262 | $74 |
| Diagnostic exam of voice box using a flexible endoscope | 19 | $1,819 | $96 |
| Removal of impacted ear wax | 29 | $1,290 | $39 |
2018: 10 services
| Short return visit (20+ min) | 176 | $13,279 | $54 |
| New patient visit (30+ min) | 103 | $7,855 | $76 |
| New patient visit (45+ min) | 64 | $7,423 | $116 |
| Return visit (30+ min) | 49 | $4,632 | $83 |
| Diagnostic exam of voice box using an endoscope | 21 | $4,243 | $193 |
| Removal of impacted ear wax | 87 | $3,015 | $32 |
| Comprehensive hearing and speech recognition test | 49 | $1,557 | $30 |
| Diagnostic exam of voice box using a flexible endoscope | 14 | $1,238 | $83 |
| Test for eardrum and muscle function | 48 | $857 | $17 |
| Short return visit | 11 | $387 | $32 |
2017: 6 services
| Short return visit (20+ min) | 177 | $14,257 | $54 |
| New patient visit (45+ min) | 86 | $9,925 | $115 |
| Return visit (30+ min) | 82 | $7,195 | $77 |
| New patient visit (30+ min) | 96 | $7,160 | $75 |
| Removal of impacted ear wax | 158 | $6,712 | $35 |
| Diagnostic exam of voice box using a flexible endoscope | 28 | $2,560 | $85 |
2016: 6 services
| New patient visit (45+ min) | 222 | $22,765 | $103 |
| Return visit (30+ min) | 131 | $14,392 | $76 |
| Short return visit (20+ min) | 139 | $11,068 | $49 |
| Removal of impacted ear wax | 180 | $9,767 | $37 |
| Diagnostic exam of voice box using a flexible endoscope | 21 | $2,021 | $92 |
| New patient visit (30+ min) | 18 | $1,389 | $77 |
2015: 6 services
| New patient visit (45+ min) | 210 | $22,334 | $106 |
| Return visit (30+ min) | 136 | $16,420 | $78 |
| Removal of impacted ear wax | 152 | $8,118 | $38 |
| Short return visit (20+ min) | 76 | $5,415 | $54 |
| Exam of the nose and throat using an endoscope | 20 | $2,354 | $112 |
| New patient visit (30+ min) | 23 | $1,629 | $71 |
2014: 5 services
| New patient visit (45+ min) | 132 | $15,638 | $118 |
| Return visit (30+ min) | 121 | $13,639 | $78 |
| Removal of impacted ear wax | 120 | $5,925 | $39 |
| Short return visit (20+ min) | 35 | $2,160 | $51 |
| New patient visit (30+ min) | 14 | $1,187 | $85 |
2013: 5 services
| Return visit (30+ min) | 183 | $22,355 | $77 |
| New patient visit (45+ min) | 168 | $18,484 | $110 |
| Removal of impacted ear wax | 129 | $7,366 | $41 |
| Exam of the nose and throat using an endoscope | 17 | $2,187 | $121 |
| Short return visit (20+ min) | 32 | $1,782 | $52 |
Medicaid work
$20,399 in 2024
Medicaid paid $20,399 for 30 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit | 30 | $20,399 |
| 2024 | 30 | 1 | 28 | $20,399 |
| 2023 | 554 | 17 | 38 | $28,123 |
| 2022 | 1,367 | 17 | 51 | $64,061 |
| 2021 | 1,345 | 10 | 71 | $85,157 |
| 2020 | 1,336 | 7 | 51 | $83,656 |
| 2019 | 505 | 6 | 41 | $26,130 |
| 2018 | 324 | 6 | 29 | $22,391 |
See the largest Medicaid services in earlier years
2023
| OFF/OP CNSLTJ NEW/EST MOD 40 | 96 | $7,764 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 92 | $6,096 |
| New patient visit (45+ min) | 76 | $5,965 |
| Service | 20 | $2,415 |
| Short return visit (20+ min) | 68 | $1,947 |
| Return visit (30+ min) | 32 | $1,112 |
| Injection, dexamethasone sodium phosphate, 1 mg | 12 | $742 |
| SARSCOV CORONAVIRUS AG IA | 15 | $579 |
| Injection, ondansetron hydrochloride, per 1 mg | 13 | $518 |
| Service | 14 | $355 |
| Ringers lactate infusion, up to 1000 cc | 16 | $350 |
| Removal of impacted ear wax | 16 | $281 |
2022
| New patient visit (45+ min) | 199 | $17,563 |
| New patient visit (30+ min) | 221 | $13,120 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 75 | $8,510 |
| Return visit (30+ min) | 129 | $6,307 |
| Short return visit (20+ min) | 200 | $6,304 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 73 | $6,140 |
| Removal of impacted ear wax | 86 | $2,761 |
| Service | 19 | $2,215 |
| SARSCOV CORONAVIRUS AG IA | 13 | $528 |
| Service | 13 | $331 |
| Ringers lactate infusion, up to 1000 cc | 15 | $187 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 12 | $96 |
2021
| Return visit (30+ min) | 424 | $25,563 |
| New patient visit (45+ min) | 226 | $19,141 |
| New patient visit (30+ min) | 202 | $15,417 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 121 | $14,128 |
| Short return visit (20+ min) | 217 | $6,961 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 25 | $1,747 |
| Removal of impacted ear wax | 49 | $1,587 |
| Ringers lactate infusion, up to 1000 cc | 33 | $279 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 24 | $173 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 24 | $159 |
2020
| New patient visit (45+ min) | 394 | $35,302 |
| Return visit (30+ min) | 372 | $20,296 |
| Short return visit (20+ min) | 351 | $10,721 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 75 | $8,352 |
| New patient visit (30+ min) | 102 | $7,113 |
| Removal of impacted ear wax | 30 | $991 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12 | $881 |
2019
| New patient visit (30+ min) | 160 | $9,223 |
| New patient visit (45+ min) | 96 | $6,625 |
| Short return visit (20+ min) | 156 | $4,630 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 20 | $3,072 |
| Return visit (30+ min) | 61 | $2,522 |
| Service | 12 | $57 |
2018
| New patient visit (30+ min) | 138 | $7,861 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 29 | $4,503 |
| Short return visit (20+ min) | 83 | $3,752 |
| Comprehensive audiometry threshold evaluation and speech recognition | 40 | $3,024 |
| New patient visit (45+ min) | 21 | $2,827 |
| Tympanometry and reflex threshold measurements | 13 | $425 |
Drugs they prescribed that Part D paid
$5,749
Pharmacies billed $5,749 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
215 generic and 22 brand-name prescriptions · $5,749 in drug cost · 58 antibiotic prescriptions to 53 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciprofloxacin-Dexamethasone | 13 | $2,039 | $157 |
| Ipratropium | 24 | $609 | $25 |
| Amoxicillin-Clavulanate Potass | 21 | $366 | $17 |
| Levocetirizine Dihydrochloride | 33 | $167 | $5 |
| Azithromycin | 25 | $141 | $6 |
See all 7 drugs
| Ciprofloxacin-Dexamethasone | 13 | $2,039 | $157 |
| Ipratropium | 24 | $609 | $25 |
| Amoxicillin-Clavulanate Potass | 21 | $366 | $17 |
| Levocetirizine Dihydrochloride | 33 | $167 | $5 |
| Azithromycin | 25 | $141 | $6 |
| Chlorhexidine Gluconate | 24 | $124 | $5 |
| Prednisone | 33 | $45 | $1 |
Year by year
| 2024 | 237 | 123 | None | 9% | $5,749 |
| 2023 | 182 | 108 | None | None | $5,700 |
| 2022 | 510 | 201 | 5% (23) | 3% | $12,315 |
| 2021 | 524 | 199 | 4% (19) | None | $10,261 |
| 2020 | 638 | 223 | None | 3% | $15,981 |
| 2019 | 438 | 187 | None | 6% | $10,383 |
| 2018 | 553 | 238 | None | 9% | $16,906 |
| 2017 | 523 | 241 | None | 12% | $16,503 |
| 2016 | 456 | 187 | 3% (14) | 16% | $16,903 |
| 2015 | 816 | 332 | 4% (31) | 21% | $43,482 |
| 2014 | 889 | 363 | 4% (34) | 24% | $47,054 |
| 2013 | 924 | 367 | 4% (40) | 24% | $45,051 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Levocetirizine Dihydrochloride | 53 | $791 | $15 |
| Ipratropium | 14 | $530 | $38 |
| Amoxicillin-Clavulanate Potass | 12 | $198 | $16 |
| Chlorhexidine Gluconate | 26 | $129 | $5 |
| Azithromycin | 17 | $93 | $5 |
| Prednisone | 20 | $24 | $1 |
2022: 11 drugs
| Ciprofloxacin-Dexamethasone | 14 | $2,380 | $170 |
| Ofloxacin | 17 | $1,846 | $109 |
| Levocetirizine Dihydrochloride | 100 | $1,608 | $16 |
| Ipratropium | 32 | $1,284 | $40 |
| Amoxicillin-Clavulanate Potass | 74 | $801 | $11 |
| Chlorhexidine Gluconate | 56 | $373 | $7 |
| Mometasone Furoate | 13 | $215 | $17 |
| Hydrocodone-Acetaminophen | 20 | $155 | $8 |
| Prednisone | 88 | $137 | $2 |
| Azithromycin | 21 | $136 | $6 |
| Famotidine | 11 | $52 | $5 |
2021: 12 drugs
| Levocetirizine Dihydrochloride | 121 | $2,164 | $18 |
| Pilocarpine | 21 | $1,294 | $62 |
| Ipratropium | 21 | $1,058 | $50 |
| Ofloxacin | 11 | $659 | $60 |
| Amoxicillin-Clavulanate Potass | 71 | $577 | $8 |
| Clarithromycin | 15 | $318 | $21 |
| Omeprazole | 25 | $246 | $10 |
| Chlorhexidine Gluconate | 38 | $219 | $6 |
| Azithromycin | 25 | $189 | $8 |
| Mometasone Furoate | 16 | $183 | $11 |
| Prednisone | 90 | $146 | $2 |
| Hydrocodone-Acetaminophen | 19 | $107 | $6 |
2020: 13 drugs
| Ciprodex | 12 | $3,060 | $255 |
| Ofloxacin | 29 | $2,531 | $87 |
| Pilocarpine | 18 | $1,781 | $99 |
| Ipratropium | 34 | $1,553 | $46 |
| Levocetirizine Dihydrochloride | 104 | $1,186 | $11 |
| Amoxicillin-Clavulanate Potass | 78 | $771 | $10 |
| Omeprazole | 45 | $584 | $13 |
| Clarithromycin | 23 | $457 | $20 |
| Chlorhexidine Gluconate | 57 | $343 | $6 |
| Prednisone | 108 | $327 | $3 |
| Azithromycin | 36 | $241 | $7 |
| Ibuprofen | 13 | $31 | $2 |
| Lorazepam | 13 | $22 | $2 |
2019: 11 drugs
| Ciprodex | 13 | $3,065 | $236 |
| Ipratropium | 40 | $1,500 | $38 |
| Ofloxacin | 14 | $952 | $68 |
| Levocetirizine Dihydrochloride | 51 | $694 | $14 |
| Clarithromycin | 20 | $537 | $27 |
| Amoxicillin-Clavulanate Potass | 39 | $391 | $10 |
| Azithromycin | 39 | $388 | $10 |
| Omeprazole | 28 | $286 | $10 |
| Chlorhexidine Gluconate | 40 | $250 | $6 |
| Prednisone | 60 | $132 | $2 |
| Ibuprofen | 21 | $79 | $4 |
2018: 13 drugs
| Ciprodex | 32 | $7,502 | $234 |
| Ipratropium | 61 | $1,957 | $32 |
| Clarithromycin | 32 | $924 | $29 |
| Levocetirizine Dihydrochloride | 46 | $786 | $17 |
| Chlorhexidine Gluconate | 65 | $557 | $9 |
| Azithromycin | 79 | $535 | $7 |
| Amoxicillin-Clavulanate Potass | 32 | $372 | $12 |
| Prednisone | 62 | $259 | $4 |
| Omeprazole | 19 | $210 | $11 |
| Mometasone Furoate | 15 | $198 | $13 |
| Montelukast | 15 | $120 | $8 |
| Ibuprofen | 16 | $109 | $7 |
| Fluticasone Propionate | 11 | $103 | $9 |
2017: 14 drugs
| Ciprodex | 25 | $5,272 | $211 |
| Qnasl | 17 | $4,219 | $248 |
| Ipratropium | 53 | $1,706 | $32 |
| Mometasone Furoate | 16 | $917 | $57 |
| Clarithromycin | 27 | $817 | $30 |
| Azithromycin | 68 | $433 | $6 |
| Levocetirizine Dihydrochloride | 28 | $375 | $13 |
| Chlorhexidine Gluconate | 52 | $366 | $7 |
| Amoxicillin-Clavulanate Potass | 37 | $353 | $10 |
| Prednisone | 59 | $202 | $3 |
| Ibuprofen | 25 | $124 | $5 |
| Omeprazole | 11 | $86 | $8 |
| Cyclobenzaprine | 21 | $84 | $4 |
| Montelukast | 11 | $78 | $7 |
2016: 12 drugs
| Ciprodex | 20 | $3,780 | $189 |
| Qnasl | 11 | $1,967 | $179 |
| Ipratropium | 54 | $1,556 | $29 |
| Clarithromycin | 36 | $1,107 | $31 |
| Levocetirizine Dihydrochloride | 17 | $545 | $32 |
| Azithromycin | 69 | $514 | $7 |
| Mometasone Furoate | 12 | $282 | $23 |
| Chlorhexidine Gluconate | 40 | $230 | $6 |
| Montelukast | 13 | $182 | $14 |
| Prednisone | 56 | $175 | $3 |
| Hydrocodone-Acetaminophen | 14 | $138 | $10 |
| Ibuprofen | 20 | $60 | $3 |
2015: 18 drugs
| Patanase | 29 | $8,360 | $288 |
| Ciprodex | 42 | $7,413 | $177 |
| Nasonex | 31 | $6,408 | $207 |
| Olopatadine | 13 | $3,784 | $291 |
| Ipratropium | 76 | $1,860 | $24 |
| Clarithromycin | 50 | $1,823 | $36 |
| Azithromycin | 84 | $720 | $9 |
| Ofloxacin | 20 | $676 | $34 |
| Hydrocodone-Acetaminophen | 30 | $474 | $16 |
| Omeprazole | 34 | $472 | $14 |
| Chlorhexidine Gluconate | 78 | $446 | $6 |
| Levocetirizine Dihydrochloride | 32 | $419 | $13 |
| Amoxicillin-Clavulanate Potass | 30 | $348 | $12 |
| Fluticasone Propionate | 18 | $253 | $14 |
| Prednisone | 69 | $233 | $3 |
| Ibuprofen | 26 | $65 | $3 |
| Lorazepam | 13 | $55 | $4 |
| Triamterene-Hydrochlorothiazid | 11 | $32 | $3 |
2014: 21 drugs
| Ciprodex | 64 | $10,188 | $159 |
| Nasonex | 46 | $7,782 | $169 |
| Patanase | 29 | $7,234 | $249 |
| Clarithromycin | 67 | $3,531 | $53 |
| Pilocarpine | 23 | $2,102 | $91 |
| Ipratropium | 50 | $1,317 | $26 |
| Azelastine | 11 | $998 | $91 |
| Chlorhexidine Gluconate | 104 | $657 | $6 |
| Omeprazole | 41 | $642 | $16 |
| Amox Tr-Potassium Clavulanate | 44 | $562 | $13 |
| Azithromycin | 49 | $492 | $10 |
| Hydrocodone-Acetaminophen | 29 | $474 | $16 |
| Fluticasone Propionate | 23 | $357 | $16 |
| Mometasone Furoate | 20 | $309 | $15 |
| Prednisone | 69 | $274 | $4 |
| Clindamycin | 22 | $258 | $12 |
| Montelukast | 14 | $162 | $12 |
| Ibuprofen | 37 | $113 | $3 |
| Cyclobenzaprine | 21 | $75 | $4 |
| Triamterene-Hydrochlorothiazid | 14 | $70 | $5 |
| Ciprofloxacin | 13 | $64 | $5 |
2013: 20 drugs
| Ciprodex | 69 | $10,305 | $149 |
| Patanase | 33 | $6,430 | $195 |
| Nasonex | 33 | $4,727 | $143 |
| Clarithromycin | 54 | $3,513 | $65 |
| Omeprazole | 60 | $1,943 | $32 |
| Ipratropium | 48 | $1,651 | $34 |
| Chlorhexidine Gluconate | 91 | $604 | $7 |
| Azithromycin | 50 | $598 | $12 |
| Amox Tr-Potassium Clavulanate | 26 | $568 | $22 |
| Hydrocodone-Acetaminophen | 31 | $450 | $15 |
| Ciprofloxacin | 68 | $401 | $6 |
| Mometasone Furoate | 25 | $398 | $16 |
| Clindamycin | 25 | $380 | $15 |
| Levocetirizine Dihydrochloride | 16 | $346 | $22 |
| Montelukast | 13 | $339 | $26 |
| Prednisone | 70 | $189 | $3 |
| Ibuprofen | 33 | $87 | $3 |
| Triamterene-Hctz | 20 | $79 | $4 |
| Lorazepam | 14 | $73 | $5 |
| Cyclobenzaprine | 18 | $71 | $4 |
Money from drug and device companies
$29 in 2025
A payment is not proof that care is biased.
| GlaxoSmithKline | Trelegy Ellipta | $29 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2025-05-27 | Trelegy Ellipta | $29 |
Professional record
- NPI
- 1538124250
- Licence
- CA G70770, NY 328863California G70770: Current · expires 2028-03-31
- Trained
- University of California, Geffen School of Medicine, 1989
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-04-18
- NPI last updated
- 2025-07-01
- NPI record certified
- 2025-07-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3838 San Dimas St Ste B231, Bakersfield, CA, 93301 · Stanford Children'S Health Specialty Services, Walnut Creek, CA, 94598
This office lists an electronic records connection.